TABLE 3.

SF-12^® Total and Subscale Scores by Time and by Cancer Treatment Status, Varenicline Duration, and Quit Status at 24 Weeks for Weeks 12 and 24

Variable	Week 12						Week 24
	Total		Physical		Emotional		Total		Physical		Emotional
	$\overline{\text{X}}$	SD	$\overline{\text{X}}$	SD	$\overline{\text{X}}$	SD	$\overline{\text{X}}$	SD	$\overline{\text{X}}$	SD	$\overline{\text{X}}$	SD
Cancer treatment status
Active (n = 43)	36.5	6.7	19.5	3.7	21.3	4.3	37.5	7.1	19.7	4.1	22	4.3
Beyond treatment (n = 60)	38.9	4.5	20.7	3.1	22.7	2.8	39.5	5.1	21.2	3.1	22.9	3.1
Varenicline duration
Standard (n = 49)	38.4	5.5	20.4	3.4	22.5	3.4	38.9	6.2	20.7	3.7	22.6	3.7
Extended (n = 54)	37.4	5.8	20.1	3.4	21.8	3.7	38.5	6	20.5	3.6	22.5	3.7
Quit status at 24 weeks
Smoking (n = 44)	36.7	5.7	19.9	3	21.1	4.1	37.8	5.5	20.3	3.1	21.9	3.5
Quit (n = 59)	38.8	5.5	20.4	3.7	22.9	3	29.3	6.4	20.8	4	23	3.7

Note. Active cancer treatment was defined as receiving cancer treatment at baseline, and beyond treatment was defined as no active treatment/in remission. Varenicline duration was 12 weeks for standard and 24 weeks for extended. Quit status at 24 weeks was self-reported as no smoking in the past 7 days and a breath carbon monoxide reading of 10 parts per million or less.